Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Acta Pharmaceutica Hungarica
|
November 21, 2007
[Cost control techniques in Hungarian medicine reimbursement]
András Inotai, József Bodrogi
International Journal of Technology Assessment in Health Care
|
April 16, 2009
Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis
András Inotai, Agnes Mészáros
Acta Poloniae Pharmaceutica
|
August 11, 2012
Determinants of NSAID choice in rheumatoid arthritis--a drug utilization study
András Inotai, Agnes Mészáros
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 8, 2019
How to solve financing gap to ensure patient access to patented pharmaceuticals in CEE countries? - the good, the bad, and the ugly ways
András Inotai, Zoltán Kaló
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 5, 2019
Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations - A meeting report from ISPOR regional conference in Warsaw, 2019
András Inotai, Bertalan Németh
Acta Pharmaceutica Hungarica
|
September 24, 2008
[Cost study of NSAID use in rheumatoid arthritis based on recent therapeutic protocols]
András Inotai, Zoltán Vincze
Acta Pharmaceutica Hungarica
|
May 11, 2012
[Risk sharing methods in middle income countries]
András Inotai, Zoltán Kaló
Acta Pharmaceutica Hungarica
|
March 17, 2011
[Assessment of the pharmaceutical expenditure in Hungary]
András Inotai, Gergo Merész, Zoltán Kaló
Acta Pharmaceutica Hungarica
|
May 7, 2010
[The assessment of oral NSAID use in patients with rheumatoid arthritis in Hungary--a cross sectional non interventional study]
András Inotai, Bernadette Rojkovich, Agnes Mészáros
Respiration; International Review of Thoracic Diseases
|
April 2, 2011
Factors associated with medication adherence in patients with chronic obstructive pulmonary disease
Tamás Ágh, András Inotai, Ágnes Mészáros
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Acta Pharmaceutica Hungarica
|
November 21, 2007
[Cost control techniques in Hungarian medicine reimbursement]
András Inotai, József Bodrogi
International Journal of Technology Assessment in Health Care
|
April 16, 2009
Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis
András Inotai, Agnes Mészáros
Acta Poloniae Pharmaceutica
|
August 11, 2012
Determinants of NSAID choice in rheumatoid arthritis--a drug utilization study
András Inotai, Agnes Mészáros
Expert Review of Pharmacoeconomics & Outcomes Research
|
December 8, 2019
How to solve financing gap to ensure patient access to patented pharmaceuticals in CEE countries? - the good, the bad, and the ugly ways
András Inotai, Zoltán Kaló
Expert Review of Pharmacoeconomics & Outcomes Research
|
June 5, 2019
Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations - A meeting report from ISPOR regional conference in Warsaw, 2019
András Inotai, Bertalan Németh
Acta Pharmaceutica Hungarica
|
September 24, 2008
[Cost study of NSAID use in rheumatoid arthritis based on recent therapeutic protocols]
András Inotai, Zoltán Vincze
Acta Pharmaceutica Hungarica
|
May 11, 2012
[Risk sharing methods in middle income countries]
András Inotai, Zoltán Kaló
Acta Pharmaceutica Hungarica
|
March 17, 2011
[Assessment of the pharmaceutical expenditure in Hungary]
András Inotai, Gergo Merész, Zoltán Kaló
Acta Pharmaceutica Hungarica
|
May 7, 2010
[The assessment of oral NSAID use in patients with rheumatoid arthritis in Hungary--a cross sectional non interventional study]
András Inotai, Bernadette Rojkovich, Agnes Mészáros
Respiration; International Review of Thoracic Diseases
|
April 2, 2011
Factors associated with medication adherence in patients with chronic obstructive pulmonary disease
Tamás Ágh, András Inotai, Ágnes Mészáros
Page
of 5